trial
as of 2026-07-01Extended Specialized Assertive Intervention for First Episode Psychosis
NCTId NCT00914238
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
400 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2009-07
Primary completion
2015-06
Eligibility
ALL · 18 Years · 37 Years
Interventions & indications
Sponsors
University of CopenhagenLead Sponsor
Region Capital DenmarkCollaborator
Medical Research CouncilCollaborator
Aarhus University HospitalCollaborator
Investigators
1
Merete Nordentoft, MD, PhD, MPHPrincipal Investigator
Sites
2 total
Copenhagen, DenmarkCopenhagen, Denmark
Facts & assertions
4 sourced
Enrollment
400
Phase
NA
Primary Completion Date
2015-06
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
indication
indication
indication
investigator